What Washington Research Foundation does

Washington Research Foundation is a Seattle-based nonprofit technology transfer foundation founded in 1981 by Tom Cable, Bill Gates Sr., and Hunter Simpson to commercialize inventions arising from Washington state research institutions under the Bayh-Dole Act. Operating with a team of approximately 15 staff from its Eastlake Avenue East headquarters—which also houses the 15,000-square-foot WRF Venture Center subleased to portfolio startups—the foundation runs three integrated programs: a licensing program that has returned more than $445 million to Washington nonprofit research institutions since inception, a grantmaking program that has deployed more than $190 million in grants since 1993 (with $16 million awarded in FY2025 and $17.8 million in FY2026), and WRF Capital, a venture investment vehicle deploying roughly $5 million annually into Washington-state spinouts with initial checks of $100,000 to $2 million.

WRF's product surface spans six grant programs—Technology Commercialization Grants (phased from $10,000 to $1 million in direct costs), WRF Postdoctoral Fellowships (12 new fellows per year, 102 awarded since 2018 across nine institutions), Student Programs (undergraduate research, ARCS fellowships, entrepreneurship competitions), Building the Innovation Ecosystem Grants (including over $32 million pledged to BioInnovation initiatives such as the Seattle Hub for Synthetic Biology), IND-Enabling/Clinical Studies Grants, and Planning Grants—plus the WRF Venture Analysts training program. The portfolio comprises technology platforms developed by funded startups spanning AI-enabled protein design (Lila Biologics, Archon Biosciences, Accipiter Biosciences, Monod Bio, Arzeda), synthetic biology screening (A-Alpha Bio's AlphaSeq), AI-powered 3D spatial pathology (Alpenglow Biosciences), conversational analytics (mpathic), and high-throughput cancer drug testing (SEngine Precision Medicine).

The business model is endowment-funded: licensing royalties and investment returns generate an annual grantmaking and reinvestment budget rather than producing a profit motive. Distribution occurs through direct institutional engagement with five core research partners and online application portals, with no commercial sales motion. WRF's geographic mandate is restricted to Washington state, and its sub-brand WRF Capital functions as the venture investment arm under the same legal entity.

Name

Washington Research Foundation

Legal name

Washington Research Foundation

Website

https://wrfseattle.org

Company type

Private

Founded year

1981

Operating status

Operating

Headcount range

11–50 employees

Short description

Washington Research Foundation is a Seattle-based nonprofit technology transfer foundation founded in 1981 that licenses intellectual property from Washington state research institutions, reinvesting proceeds through grants, postdoctoral fellowships, and venture investments via WRF Capital to fund translational life sciences research and Washington-state startup spinouts.

Ownership category

akta.pro rank

Product category

Research Foundation & Technology Transfer Services

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Patent Owners & Lessors (6794), Services-Engineering, Accounting, Research, Management (8700)

akta.pro primary industry

Research & Science Grantmaking Foundations (BPAGAKAI)

akta.pro secondary industry

Health & Medical Research Grantmaking Foundations (BPAGAKAL)

Keywords

• Technology transfer services
• Research grant funding
• Venture capital investing
• Intellectual property licensing
• Life sciences funding

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Others, Personnel, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Licensing Revenue: WRF earns revenue through licensing agreements for technologies developed at Washington state research institutions. The foundation has earned over $445 million for the University of Washington and other nonprofit research institutions through its licensing program.
2. Grantmaking (Giving): WRF provides grants to support life sciences and enabling technology research at nonprofit research institutions. WRF Capital provides equity investments in early-stage startup companies spinoff from research institutions. Both activities are funded by the licensing revenue endowment.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

Core offering

Washington Research Foundation is a nonprofit technology transfer foundation that licenses inventions from Washington state nonprofit research institutions, returning licensing proceeds to originating institutions and reinvesting returns into a multi-program grantmaking and venture investment operation. Through phased Technology Commercialization Grants (up to $1M), WRF Capital venture investments ($100K–$2M initial checks), Postdoctoral Fellowships, Student Programs, and ecosystem-building grants, WRF bridges translational academic research and commercial development in Washington state.

Product overview

Washington Research Foundation operates as a nonprofit technology transfer foundation offering grant programs and venture investment services rather than a unified software product. The organization's primary offerings include WRF Capital (startup investments in Washington state spinouts), Technology Commercialization Grants (phased funding from $10K to $1M), WRF Postdoctoral Fellowships (supporting up to 12 scientists annually), Student Programs (STEM research and entrepreneurship funding), and Building the Innovation Ecosystem Grants (strategic funding including BioInnovation Grants exceeding $32M). The portfolio includes diverse technology platforms developed by funded startups such as A-Alpha Bio's AlphaSeq synthetic biology screening platform, Archon Biosciences' Antibody Cage technology, Accipiter Biosciences' de novo protein design platform, Alpenglow Biosciences' AI-powered 3D spatial biology system, and mpathic's AI-driven conversational analytics platform. The foundation's mission focuses on life sciences and enabling technologies, with over $190M in grants awarded since 1993 and more than 130 startups funded through WRF Capital.

Differentiator

Problem solved

Functional benefit

Products and services

• WRF Capital WRF Capital is the venture investment vehicle of Washington Research Foundation, investing approximately $5 million annually in early-stage startup companies (pre-seed to Series A) based in Washington state and spun out from nonprofit research institutions including UW, WSU, Fred Hutch, and ISB. Initial investments range from $100,000 to $2 million with reserves for follow-on financing, focused on life sciences and enabling technology applications.
• Technology Commercialization Grants

Quantifiable outcome

• Over $445 million earned for Washington nonprofit research institutions through licensing program
• +3 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability13 records

Partnerships

Eight partnerships are on record, tiered minor, core, major and strategic.

• McKinstryminorOthers · 30 September 2025Jamie Pedersen, Washington State Senator and Executive Vice President/General Counsel at McKinstry, joined WRF's board of directors. McKinstry is a Seattle-based construction and engineering corporation.
• University of WashingtoncoreStrategic or Co-development PartnerPrimary affiliated research institution; WRF has earned over $445 million for UW through licensing program. WRF supports UW through grants, postdoctoral fellowships, student programs, and equity investments in UW spinouts including Monod Bio, Accipiter Biosciences, and Xaira Therapeutics.
• Washington State UniversitycoreStrategic or Co-development PartnerKey affiliated research institution receiving grants for technology commercialization. WRF supports WSU through the Commercialization Gap Fund, student programs, and investments in WSU spinouts.
• Fred Hutchinson Cancer Research CentercoreStrategic or Co-development PartnerMajor research institution with multiple portfolio companies including Proniras, Tune Therapeutics, KayoThera, and others. WRF supports Fred Hutch through grants and investments including the 'Bridging the Clinical Gap' collaboration.
• Seattle Children's Research InstitutecoreStrategic or Co-development PartnerResearch institution receiving support through the $12.5 million 'Invent at Seattle Children's Postdoctoral Scholars Program' and investments in startups including AdaptX and Dopl Technologies.
• Institute for Systems BiologycoreStrategic or Co-development PartnerResearch institution with portfolio companies including Xaira Therapeutics. WRF supports ISB through the Innovator Award Program and investments.
• Seattle Hub for Synthetic Biology (SeaHub)majorStrategic or Co-development PartnerWRF pledged over $10 million to support SeaHub, a major initiative to advance cell and genome technologies. WRF also supports SeaBridge fellowship program at the hub. SeaBridge program supports postdoctoral fellows from UW and Fred Hutch.
• Creative Destruction Lab (CDL-Seattle)strategicStrategic or Co-development PartnerWRF provides support to CDL-Seattle, a global startup program for seed-stage, science-based companies located at UW's Foster School of Business. Partnership includes Microsoft, Allen Institute for AI, and other supporters.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Wisconsin Alumni Research Foundation (WARF): WARF is the nation's oldest and largest university-affiliated technology transfer foundation, founded in 1925 to commercialize UW-Madison research. Like WRF, it earns licensing royalties and reinvests proceeds into research grants — making it the gold-standard comparable for WRF's licensing-plus-grantmaking model.
• Research Foundation for the State University of New York: The Research Foundation for SUNY administers grants, manages technology transfer, and supports commercialization across SUNY's 64 campuses. Its combination of research administration, IP management, and economic development programs makes it structurally comparable to WRF, though operating at much larger scale.
• Arnold and Mabel Beckman Foundation: The Beckman Foundation supports young scientists through grants and research programs at major research universities. Its mission to fund translational research and cultivate scientific talent is structurally similar to WRF's postdoctoral fellowship and grantmaking programs.
• The Lemelson Foundation: The Lemelson Foundation supports invention and innovation through grants to universities and inventors, including MIT's Lemelson-MIT Program. Carol Dahl, WRF board member, previously served as Lemelson's Executive Director — reflecting close organizational alignment around invention-based research grantmaking.
• Cornell Research Foundation: Cornell's Center for Technology Licensing (CTL) and affiliated research foundation manage IP commercialization for Cornell University inventions. The structure of university-based patent licensing with reinvestment into research is directly comparable to WRF's operating model.
• Purdue Research Foundation: Purdue Research Foundation operates as a technology transfer and commercialization arm for Purdue University, managing patent licensing, the Purdue Foundry startup accelerator, and research park operations. It mirrors WRF's combination of licensing, venture investment, and ecosystem-building activities tied to a single research university ecosystem.

Emerging players

• University City Science Center: The University City Science Center in Philadelphia operates a research park, startup incubator, and commercialization programs supporting academic spinouts. While more focused on incubation infrastructure than licensing, its ecosystem-building role in a regional innovation cluster parallels WRF's broader mission.

Broad incumbents

• Howard Hughes Medical Institute (HHMI): HHMI is a much larger biomedical research organization that combines research institute operations with extensive grantmaking to scientists at universities. While not a tech transfer foundation, its model of funding investigator-initiated research and translating discoveries is broadly comparable to WRF's research-support mission.
• Alfred P. Sloan Foundation: The Sloan Foundation is a major science-focused philanthropy funding basic research across STEM fields. While it does not license IP or make venture investments, its scale and focus on advancing scientific research through institutional grants makes it a comparable research-support foundation.

Regional players

• LifeArc: LifeArc is a UK-based self-funding medical research charity that licenses IP, makes venture investments, and supports translational research — a structural analog to WRF. Its geographic separation from Washington state makes it a regional rather than direct competitor, but the business model is highly comparable.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/washington-research-foundation
• Xx.com/wrfseattle
• Facebookfacebook.com/21621734279

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments62 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Washington Research Foundation